)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Square Pharmaceuticals
Square Pharmaceuticals (SQURPHARMA) investor relations material
Square Pharmaceuticals Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary10 Nov, 2026
Executive summary
Q1 FY26/27 consolidated net revenue was Tk 22.44bn vs Tk 21.59bn YoY; profit for the period was Tk 7.78bn vs Tk 7.40bn.
Consolidated EPS increased to Tk 8.77 from Tk 8.35; cash and cash equivalents stood at Tk 55.41bn at 30 Sep 2026.
Financial highlights
Consolidated gross profit was Tk 12.18bn vs Tk 11.24bn; profit from operations was Tk 7.60bn vs Tk 7.02bn.
Consolidated profit before tax reached Tk 8.85bn vs Tk 8.35bn; income tax expense was Tk 1.68bn vs Tk 1.54bn.
Standalone net revenue was Tk 17.59bn vs Tk 16.39bn; profit after tax was Tk 4.95bn vs Tk 4.70bn.
Key financial ratios and metrics
Consolidated NAV per share was Tk 187.35 at 30 Sep 2026, up from Tk 178.99 at 30 Jun 2026.
Consolidated net operating cash flow per share fell to Tk 5.49 from Tk 7.55 YoY; standalone NOCF per share was Tk 5.05 vs Tk 7.15.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Square Pharmaceuticals
- Strong revenue and profit growth, with higher EPS and robust operating cash flow.SQURPHARMA
Q3 2026 - Six-month net profit surged 16% year-over-year on strong revenue and cash flow growth.SQURPHARMAQ2 25/26
- Consolidated profit up 14.54% with strong exports and a 120% cash dividend; standalone profit dipped.SQURPHARMAQ4 24/25
- Net revenue grew 21.7% and net profit after tax rose 21.5% year-over-year in Q1 FY2025-26.SQURPHARMAQ1 25/26
- Consolidated profit up 10.26% on strong exports and subsidiary growth; dividend raised.SQURPHARMAQ4 23/24
- Consolidated Q1 profit was stable, with EPS up and cash flow per share down year-over-year.SQURPHARMAQ1 24/25
- Double-digit profit and revenue growth, strong balance sheet, and robust investment income.SQURPHARMAQ3 2025
- Net profit up 13% to Tk. 12.70B; EPS and NAV per share both increased year-over-year.SQURPHARMAQ2 2025
- Net profit rose 13% year-over-year, with EPS at Tk. 14.32 and strong asset growth.SQURPHARMAQ2 24/25
Next Square Pharmaceuticals earnings date
Q4 202616 Nov, 2026
Square Pharmaceuticals
Next Square Pharmaceuticals earnings date
Q4 202616 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing, marketing, and distribution of pharmaceutical products. The company produces a wide range of formulations, including tablets, capsules, injectables, syrups, and topical treatments, covering multiple therapeutic areas such as cardiology, gastroenterology, antibiotics, and pain management. It also manufactures active pharmaceutical ingredients (APIs) and exports its products to various international markets. Square Pharmaceuticals operates multiple production facilities and focuses on research and development to expand its product portfolio. The company is headquartered in Dhaka, Bangladesh, and its shares are listed on the DSE and CSE.